Technical Analysis for VKTX - Viking Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 4.61 4.77% 0.21
VKTX closed down 1.57 percent on Friday, April 3, 2020, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical VKTX trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 4.77%
Boomer Sell Setup Bearish Swing Setup 4.77%
Spinning Top Other 4.77%
NR7 Range Contraction 4.77%
Inside Day Range Contraction 4.77%
Wide Bands Range Expansion 4.77%
20 DMA Resistance Bearish 3.13%
Wide Bands Range Expansion 3.13%
20 DMA Resistance Bearish 5.98%
Doji - Bullish? Reversal 5.98%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for metabolic and endocrine disorders. Its lead clinical program includes VK0612, an orally available drug candidate for the treatment of type 2 diabetes. The company is also developing VK5211, an orally available drug candidate, which has completed Phase I trial for the treatment of cancer cachexia, a disease characterized by an uncontrolled decline in muscle mass. In addition, it is developing VK0214, a novel liver-selective thyroid hormone receptor beta agonist for lipid disorders, such as dyslipidemia and nonalcoholic steatohepatitis, as well as other preclinical programs for metabolic diseases and anemia. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.
Medicine Health Biopharmaceutical Cancer Medical Specialties Disease Diabetes Medication Treatment Of Cancer Anemia Hepatitis Geriatrics Metabolic Diseases Dyslipidemia Non Alcoholic Fatty Liver Disease Steatohepatitis Lipid Disorders Rehabilitation Medicine

Is VKTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.03
52 Week Low 3.26
Average Volume 1,387,970
200-Day Moving Average 6.96
50-Day Moving Average 5.66
20-Day Moving Average 4.43
10-Day Moving Average 4.48
Average True Range 0.44
ADX 34.52
+DI 14.91
-DI 24.38
Chandelier Exit (Long, 3 ATRs ) 5.00
Chandelier Exit (Short, 3 ATRs ) 4.59
Upper Bollinger Band 5.48
Lower Bollinger Band 3.39
Percent B (%b) 0.48
BandWidth 47.12
MACD Line -0.35
MACD Signal Line -0.45
MACD Histogram 0.0991
Fundamentals Value
Market Cap 121.87 Million
Num Shares 27.7 Million
EPS -0.83
Price-to-Earnings (P/E) Ratio -5.30
Price-to-Sales 0.00
Price-to-Book 10.84
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.81
Resistance 3 (R3) 4.82 4.70 4.74
Resistance 2 (R2) 4.70 4.60 4.69 4.71
Resistance 1 (R1) 4.55 4.53 4.49 4.54 4.69
Pivot Point 4.43 4.43 4.40 4.42 4.43
Support 1 (S1) 4.28 4.33 4.22 4.27 4.11
Support 2 (S2) 4.16 4.26 4.15 4.09
Support 3 (S3) 4.01 4.16 4.06
Support 4 (S4) 4.00